Silicon Valley Capital Partners

Position in OGN — Organon & Co.

CIK 1673633 SAN JOSE, CA

Position in OGN

as of Mar 31, 2026 · filed May 19, 2026 Compact

Position Value

$491

-$89 QoQ

Shares Held

+1.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Silicon Valley Capital Partners holds $14,966,250 across 12 Drug Manufacturers - General names. OGN ranks #12 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	13,009	$11,965,287
2	JNJ	Johnson & Johnson	9,659	$2,361,045
3	PFE	Pfizer Inc	7,397	$207,707
4	AMGN	Amgen Inc	487	$171,350
5	ABBV	AbbVie Inc.	580	$126,144
6	BMY	Bristol Myers Squibb Co	1,154	$69,990
7	MRK	Merck & Co., Inc.	380	$45,710
8	NVO	Novo Nordisk A S	276	$10,143

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$491	82	+1.2%	Shares	Sole	2026-05-19
2025-12-31	$580	81	0.0%	Shares	Sole	2026-02-13
2025-09-30	$865	81	+76.1%	Shares	Sole	2025-11-17
2025-06-30	$445	46	0.0%	Shares	Sole	2025-09-11
2025-03-31	$684	46	+2.2%	Shares	Sole	2025-05-28
2024-12-31	$671	45	0.0%	Shares	Sole	2025-01-29
2024-09-30	$860	45	+2.3%	Shares	Sole	2024-10-30
2024-06-30	$910	44	+2.3%	Shares	Sole	2024-10-30
2024-03-31	$808	43	0.0%	Shares	Sole	2024-04-29
2023-12-31	$620	43	+2.4%	Shares	Sole	2024-02-14
2023-09-30	$729	42	+2.4%	Shares	Sole	2023-11-06
2023-06-30	$853	41	0.0%	Shares	Sole	2023-08-14
2023-03-31	$964	41	+2.5%	Shares	Sole	2023-05-10
2022-12-31	$1,117	40	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.